Difficulty: Medium
Average Score: 88%
Practice
Children with high-risk neuroblastoma have poor survival. Current treatment consists of all the following EXCEPT
Correct answer
E
Rationale
In the case of children with high-risk neuroblastoma, the correct answer is "E) immunotherapy" as it has been shown to be an effective treatment approach. Immunotherapy helps the body's immune system recognize and attack cancer cells, improving survival rates in this population.
Option A) surgery is often used to remove the primary tumor in neuroblastoma cases, making it a standard part of treatment.
Option B) intensive chemotherapy is also commonly employed to target and kill cancer cells, particularly in aggressive cases like high-risk neuroblastoma.
Option C) radiation therapy may be used to further target and eliminate cancer cells, especially in cases where surgery and chemotherapy are not sufficient.
Option D) allogeneic bone marrow transplantation may be considered in some cases to replace damaged bone marrow with healthy donor cells, but it is not a primary treatment for high-risk neuroblastoma.
Educationally, understanding the various treatment modalities for pediatric cancers like neuroblastoma is crucial for nurses caring for these patients. It allows them to provide comprehensive care, support treatment adherence, and educate families on what to expect during the treatment process. This knowledge empowers nurses to advocate for their patients and collaborate effectively with the healthcare team to optimize outcomes.
Option A) surgery is often used to remove the primary tumor in neuroblastoma cases, making it a standard part of treatment.
Option B) intensive chemotherapy is also commonly employed to target and kill cancer cells, particularly in aggressive cases like high-risk neuroblastoma.
Option C) radiation therapy may be used to further target and eliminate cancer cells, especially in cases where surgery and chemotherapy are not sufficient.
Option D) allogeneic bone marrow transplantation may be considered in some cases to replace damaged bone marrow with healthy donor cells, but it is not a primary treatment for high-risk neuroblastoma.
Educationally, understanding the various treatment modalities for pediatric cancers like neuroblastoma is crucial for nurses caring for these patients. It allows them to provide comprehensive care, support treatment adherence, and educate families on what to expect during the treatment process. This knowledge empowers nurses to advocate for their patients and collaborate effectively with the healthcare team to optimize outcomes.